NKGen Biotech, Inc. Quarterly Debt-to-equity in % from Q1 2022 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: NKGen Biotech, Inc. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q2 2024.
NKGen Biotech, Inc. Debt-to-equity for the quarter ending June 30, 2024 was -133 %, a 173% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	-133	-84.2	-173%	Jun 30, 2024
Q1 2024	-133	-104	-356%	Mar 31, 2024
Q4 2023	-134	-101	-312%	Dec 31, 2023
Q3 2023	-169	-146	-624%	Sep 30, 2023
Q2 2023	-48.7	-8.53	-21.2%	Jun 30, 2023
Q1 2023	-29.2	+47.6	+62%	Mar 31, 2023
Q4 2022	-32.4			Dec 31, 2022
Q3 2022	-23.4			Sep 30, 2022
Q2 2022	-40.2			Jun 30, 2022
Q1 2022	-76.8			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.